Monopar Therapeutics (MNPR) Shares Outstanding (Weighted Average) (2017 - 2025)
Quarterly results put Shares Outstanding (Weighted Average) at $7.4 million for Q4 2025, up 95.53% from a year ago — trailing twelve months through Dec 2025 was $7.4 million (up 95.53% YoY), and the annual figure for FY2025 was $7.4 million, up 95.53%.
Monopar Therapeutics has reported Shares Outstanding (Weighted Average) over the past 9 years, most recently at $7.4 million for Q4 2025.
- Shares Outstanding (Weighted Average) reached $7.4 million in Q4 2025 per MNPR's latest filing, up from $7.1 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $13.3 million in Q2 2023 and bottomed at $2.8 million in Q4 2023.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $9.8 million (2021), compared with a mean of $8.7 million.
- The largest annual shift saw Shares Outstanding (Weighted Average) plummeted 78.26% in 2023 before it surged 118.62% in 2025.
- Over 5 years, Shares Outstanding (Weighted Average) stood at $12.5 million in 2021, then rose by 1.98% to $12.7 million in 2022, then tumbled by 78.26% to $2.8 million in 2023, then skyrocketed by 37.08% to $3.8 million in 2024, then surged by 95.53% to $7.4 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for MNPR at $7.4 million in Q4 2025, $7.1 million in Q3 2025, and $7.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.04 Bn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 7.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.41 Mn |
| Sep 30, 2025 | 7.12 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 6.99 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 2.77 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Jun 30, 2023 | 13.26 Mn |
| Mar 31, 2023 | 13.11 Mn |
| Dec 31, 2022 | 12.72 Mn |
| Sep 30, 2022 | 12.66 Mn |
| Jun 30, 2022 | 12.63 Mn |
| Mar 31, 2022 | 12.60 Mn |
| Dec 31, 2021 | 12.47 Mn |
| Sep 30, 2021 | 12.58 Mn |
| Jun 30, 2021 | 12.57 Mn |
| Mar 31, 2021 | 12.14 Mn |
| Dec 31, 2020 | 10.96 Mn |
| Sep 30, 2020 | 10.79 Mn |
| Jun 30, 2020 | 10.65 Mn |
| Mar 31, 2020 | 10.61 Mn |
| Dec 31, 2019 | 9.32 Mn |
| Sep 30, 2019 | 9.29 Mn |
| Jun 30, 2019 | 9.29 Mn |
| Mar 31, 2019 | 9.29 Mn |
| Dec 31, 2018 | 9.29 Mn |
| Sep 30, 2018 | 9.29 Mn |
| Jun 30, 2018 | 9.29 Mn |
| Mar 31, 2018 | 9.29 Mn |
| Dec 31, 2017 | 8.78 Mn |
| Sep 30, 2017 | 8.87 Mn |
| Jun 30, 2017 | 8.48 Mn |
| Mar 31, 2017 | 8.34 Mn |